“ you man I dropped acid and did all that.......stuff I said”
Easily. You have no life.
Your ST life has been about believing in pedo rings run by celebrities and politicians. And now you’re a full time Trump ball sucker.
Everyone laughs at you and your sad life. No one buys anything other than you’re a 4channity poster.
“ you man I dropped acid and did all that.......stuff I said”
, I believe TSA's stories. Makes his Ukranium One QAnon baby cannibal pizza sex dungeon beliefs really ing sad tho.
Careful
He’s heavily armed and shoots through walls........with certain caliber bullets that do special stuff......
Anyone else remember that rambling show?
Wait what? TSA please do tell.
Did you have bullet time sex with a famous someone on this particular sexcapade?
“ yeah!!!”
“Before I forget......Acid man”
I once dropped acid and banged the girl next door. Now that felt crazy,like ng the ocean![]()
called it
Gilead halts testing of their drug. European markets sink at the news
called it. it was all marketing hype
Dr Facci strikes again
“there will be no miracle drug for this” - Dear Dr Facci
Purplish Lesions On Feet Could Be Sign Of Virus
It seems that many otherwise asymptomatic people are reporting the presence of painful purplish lesions on their toes.
https://www.huffpost.com/entry/foot-lesions-coronavirus-symptom_n_5ea1c3d3c5b6a4fee73a1dc9?ncid=newsltushp mgnews
Lysol martini will fix ya right up
500 watts of UVC to burn the toes off
I prefer injecting the disinfectant straight into the toes.
You think I'm making this up, that's funny. Anyways I'll stop derailing the thread now, but damn that was some good pussy.
Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment
Cedars-Sinai-Developed ‘Healight’ Medical Device Platform Technology Being Studied as a Potential First-in-Class COVID-19 Treatment
Conference Call Scheduled for Tuesday, April 21, 2020 at 4:30 pm ET
ENGLEWOOD, CO / ACCESSWIRE / April 20, 2020 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the “Company”), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today that it has signed an exclusive worldwide license from Cedars-Sinai to develop and commercialize the Healight Platform Technology (“Healight”). This medical device technology platform, discovered and developed by scientists at Cedars-Sinai, is being studied as a potential first-in-class treatment for coronavirus and other respiratory infections.
The company will host a live conference call and webcast Tuesday, April 21, 2020 at 4:30 p.m. ET. Conference call details are provided at the end of this press release.
Led by Mark Pimentel, MD, the research team of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai has been developing the patent-pending Healight platform since 2016 and has produced a growing body of scientific evidence demonstrating pre-clinical safety and effectiveness of the technology as an antiviral and antibacterial treatment. The Healight technology employs proprietary methods of administering intermittent ultraviolet (UV) A light via a novel endotracheal medical device. Pre-clinical findings indicate the technology’s significant impact on eradicating a wide range of viruses and bacteria, inclusive of coronavirus. The data have been the basis of discussions with the FDA for a near-term path to enable human use for the potential treatment of coronavirus in intubated patients in the intensive care unit (ICU). Beyond the initial pursuit of a coronavirus ICU indication, additional data suggest broader clinical applications for the technology across a range of viral and bacterial pathogens. This includes bacteria implicated in ventilator associated pneumonia (VAP).
“Our team has shown that administering a specific spectrum of UV-A light can eradicate viruses in infected human cells (including coronavirus) and bacteria in the area while preserving healthy cells,” stated Dr. Pimentel of Cedars-Sinai. Ali Rezaie, MD, one of the inventors of this technology states, “Our lab at Cedars-Sinai has extensively studied the effects of this unique technology on bacteria and viruses. Based on our findings we believe this therapeutic approach has the potential to significantly impact the high morbidity and mortality of coronavirus-infected patients and patients infected with other respiratory pathogens. We are looking forward to partnering with Aytu BioScience to move this technology forward for the benefit of patients all over the world.”
The company believes the Healight platform technology has the potential to positively impact outcomes for critically ill patients infected with coronavirus and severe respiratory infections. The company licensed exclusive worldwide rights to the technology from Cedars-Sinai for all endotracheal and nasopharyngeal indications. Patents have been filed by Cedars-Sinai Department of Technology Transfer, and Aytu BioScience will manage all aspects of intellectual property prosecution and filing globally. Aytu BioScience expects to partner the product outside the U.S.
“We are honored to be partnering with Cedars-Sinai as we believe the Healight therapeutic platform has the potential to help many patients during this coronavirus pandemic and beyond,” said Josh Disbrow, Chairman and CEO of Aytu BioScience.
The Company is engaging with the research team at Cedars-Sinai and the FDA to determine an expedited regulatory process to potentially enable near-term use of the technology initially as a coronavirus intervention for critically ill intubated patients.
Disbrow continued, “This first-in-class technology has the potential to be a game changer for clinicians treating patients infected with coronavirus and other respiratory conditions, and our team is working tirelessly alongside the Cedars-Sinai team to determine the safety and effectiveness of this device in humans.”
https://www.sec.gov/Archives/edgar/d...aytu_ex991.htm
Methylene blue derivatives — suitable photoantimicrobials for blood product disinfection?
https://www.sciencedirect.com/scienc...24857900002077
https://en.wikipedia.org/wiki/Methyl...tious_diseases
When do the trials begin for injecting Clorox tho?
Ultraviolet Irradiation of Blood: “The Cure That Time Forgot”?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122858/
So you're going to defend this one too?
The ing 30% is unreal.
A cohort of cancer patients with no reported cases of SARS-CoV-2 infection: the possible preventive role of Methylene Blue
Abstract
We report the case of a cohort of 2500 French patients treated among others with methylene blue for cancer care. During the COVID-19 epidemics none of them developed influenza-like illness. Albeit this lack of infection might be by chance alone, it is possible that methylene blue might have a preventive effect for COVID-19 infection. This is in line with the antiviral activity of Chloroquine, a Methylene blue derivative. Both Chloroquine and Methylene blue have strong antiviral and anti- inflammatory properties probably linked to the change in intracellular pH and redox state.
https://riviste.fupress.net/index.ph...ticle/view/888
So you're not supposed to eat the Tide Pods, you're supposed to inject them?
It works better if you mainline it btw.Toes are for amateurs trying to hide the track marks because they worry about the opinions of others.now is not the time to be worried about that.This is to save lives.Mainline that ish
So you are Blake neighbor?
Here you go again with this defending bull . Why can't you just discuss anymore? I don't care what they come up with to help stop this thing. Drop the TDS for a minute dude.
lol tsa
thank you, man
There are currently 6 users browsing this thread. (0 members and 6 guests)